January 24 (SeeNews) - Belgian specialty biopharma company Hyloris has signed an exclusive licensing and distribution agreement with Slovenian pharmaceutical products wholesaler Salus [LJE:SALR] for its non-opioid pain treatment Maxigesic, Hyloris said on Tuesday.